Richard Daniell insider trades

Open-market stock purchases and sales by Richard Daniell, EVP, Europe Commercial at Teva Pharmaceutical Industries Ltd, from SEC Form 4 filings since Feb 9, 2018.

Recent trades

DateStockTradeValue
May 5, 2026TEVA Teva Pharmaceutical Industries LtdSold$1.1M
Mar 5, 2026TEVA Teva Pharmaceutical Industries LtdSold$548K
Mar 5, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Mar 4, 2026TEVA Teva Pharmaceutical Industries LtdSold$1.1M
Mar 4, 2026TEVA Teva Pharmaceutical Industries LtdSold$664K
Mar 4, 2026TEVA Teva Pharmaceutical Industries LtdSold$1.2M
Mar 4, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Mar 4, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Mar 4, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Mar 3, 2026TEVA Teva Pharmaceutical Industries LtdSold$2M
Mar 3, 2026TEVA Teva Pharmaceutical Industries LtdSold$2.2M
Mar 3, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Mar 3, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Jan 27, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Dec 9, 2025TEVA Teva Pharmaceutical Industries LtdSold$3.3M
Dec 9, 2025TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Dec 9, 2025TEVA Teva Pharmaceutical Industries LtdBought (not open market)—

Companies traded

  • TEVA Teva Pharmaceutical Industries Ltd: 52 sales, last May 5, 2026

Get free alerts when Richard Daniell files a new trade →